Mrs. Lynne Mary Pesklo, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 520 Knapp Hill Rd, Castle Creek, NY 13744 Phone: 607-760-2750 |
News Archive
Molecular Health signed an agreement with TestAnalytika to be its preferred distributor in the Latin American region at the 2015 ASCO Annual Meeting. TestAnalytika will begin to market and distribute Molecular Health's cancer treatment decision support product, TreatmentMAP, to patients, physicians, hospitals, laboratories, cancer centers and insurers in Latin America later this year.
Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect-raising blood pressure in a statistically significant percentage of patients. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that doctors could avoid this problem-and select drugs most suitable for their patients-by measuring blood levels of the enzyme renin through a blood test that is becoming more widely available. The study appears in the online edition of the American Journal of Hypertension.
The US Secretary of Health recently supported a recommendation that all babies born in the US are to be screened for critical heart defects, before leaving hospital. Behind this decision is a study from the Sahlgrenska Academy at the University of Gothenburg, and the West Götaland Region's maternity units in Sweden which shows that a simple test can save the lives of newborns with these heart defects.
Researchers at the University of California, San Diego School of Medicine and Children's Hospital and Health Center, San Diego have discovered that "Staph" bacteria use a protective golden armor to ward off the immune system, a finding with the potential to lead to new treatments for serious infections now increasingly resistant to standard antibiotics.
› Verified 8 days ago